biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Contact
biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Contact
biuro@scopefluidics.com
+48 22 376 21 14
RAPORT ESPI 22/2023|03-07-2023|Otrzymanie zawiadomienia z art. 19 MAR
Previous Post
RAPORT ESPI 21/2023|30-06-2023|Otrzymanie zawiadomienia z art. 19 MAR
Next Post
RAPORT ESPI 23/2023|04-07-2023|Otrzymania zawiadomienia w trybie art. 69 ustawy o ofercie
0
Shares
Related Posts
18.11.2024
Scope Fluidics Secures $30 Million from Conditional Payment Settlement with Bio-Rad Laboratories in Curiosity Diagnostics Sale
aj
0
24.09.2024
Scope Fluidics Signs Agreement for IVDR Certification of Innovative BACTEROMIC System
lk
0
04.09.2024
Notified Body Initiates IVDR Certification Readiness Assessment for BACTEROMIC System, Developed by Scope Fluidics Group
lk
0
×
